IMRONIZE Trademark

Trademark Overview

On Wednesday, January 9, 2019, a trademark application was filed for IMRONIZE with the United States Patent and Trademark Office. The USPTO has given the IMRONIZE trademark a serial number of 88254887. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 20, 2021. This trademark is owned by Merck Sharp & Dohme Corp.. The IMRONIZE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology
imronize

General Information

Serial Number88254887
Word MarkIMRONIZE
Filing DateWednesday, January 9, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 20, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Sharp & Dohme Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889
Party NameMerck Sharp & Dohme Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889

Trademark Events

Event DateEvent Description
Monday, December 20, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 20, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 10, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 10, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, June 10, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 10, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 27, 2021EXTENSION 4 GRANTED
Tuesday, April 27, 2021EXTENSION 4 FILED
Tuesday, April 27, 2021TEAS EXTENSION RECEIVED
Wednesday, October 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 26, 2020EXTENSION 3 GRANTED
Monday, October 26, 2020EXTENSION 3 FILED
Monday, October 26, 2020TEAS EXTENSION RECEIVED
Friday, April 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 8, 2020EXTENSION 2 GRANTED
Wednesday, April 8, 2020EXTENSION 2 FILED
Wednesday, April 8, 2020TEAS EXTENSION RECEIVED
Tuesday, October 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 4, 2019EXTENSION 1 GRANTED
Friday, October 4, 2019EXTENSION 1 FILED
Friday, October 4, 2019TEAS EXTENSION RECEIVED
Tuesday, May 14, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 6, 2019ASSIGNED TO EXAMINER
Wednesday, January 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 12, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

imronize oncology preparations pharmaceutical